APA (7th ed.) Citation

Y, J., H, C., W, C., L, Z., X, W., P, S., . . . J, C. (2026). Asymmetric nanozymes improve cardiac purine catabolism and alleviate oxidative stress of myocardium to treat ischemic heart disease. Journal of nanobiotechnology, 24(1), . https://doi.org/10.1186/s12951-026-04548-2

Chicago Style (17th ed.) Citation

Y, Jiang, et al. "Asymmetric Nanozymes Improve Cardiac Purine Catabolism and Alleviate Oxidative Stress of Myocardium to Treat Ischemic Heart Disease." Journal of Nanobiotechnology 24, no. 1 (2026). https://doi.org/10.1186/s12951-026-04548-2.

MLA (9th ed.) Citation

Y, Jiang, et al. "Asymmetric Nanozymes Improve Cardiac Purine Catabolism and Alleviate Oxidative Stress of Myocardium to Treat Ischemic Heart Disease." Journal of Nanobiotechnology, vol. 24, no. 1, 2026, https://doi.org/10.1186/s12951-026-04548-2.